Theralase Technologies Inc. V.TLT

Question

[Camphikefish]

Question for all the wise and experienced pharma and biotech investors who have much more insight than I do . I looked back at the original statement from Theralase pointing out Tld-1433 killed 99.99 % of the type 2 Covid strain and had yet to be tested against the type 3 strain we are exposed to at this time . Perhaps there is a new variant which makes this an irrelavant point however , if Tld-1433 is successful at destroying the type 3 virus at the same rate , does big pharma ( and the market ) have an appetite for such an effective treatment ? Given the profits yet to be realized from booster after booster , will there be an effort to possibly capture and bury this technology due to its possible overwhelming efficacy against COVID-19 ? Perhaps it is a silly question and if so , so be it . Like others , I continue to be completely confused as to why this technology / company has not gained share price momentum . If it's half as good as lab results suggest in vitro against cancers and viruses how on earth are we still floundering at such low levels ? Hence the genesis of my question . Does the profit driven mindset of big pharma and other influencers have a desire and a need for such a wonder compound which could potentially be a one and done treatment ? This keeps me awake at night even after all these years ! I'm puzzled . Seems like we should be above $5.00 by now easily but I must be missing something obviously .

[CancerSlayer]

  Whatever provides Big Pharma...1) market dominance 2) wider profit margins 3) at the lowest sale price (a high market to market cap) will be Big Pharma's chosen path.   There may be even more opportunity & money to be made with an antiviral treatment (as so few outpatient options exist for common respiratory viruses) as opposed to a vaccine...the latter (at least

[VerusSemperSors]

[VerusSemperSors]

Oops - hit post button by mistake B4: Re why SP doesn't move much IMO: Institutional investors and professional financial advisors don't touch these nano-caps & micro-caps for the most part because there just isn't enough total share value to be widely held, among other reasons, like not being sufficiently proven. That leaves small retail investors that found the stock without

[StevenBirch]

I don't think we need to attract new investors although that is obviously always welcome. What we need is to have existing shareholders who are holding it down in order to buy more at these prices to back off on the sell side because every time we move up 5 to 7 cents the sellers come in. I think there is a ton of interest in this stock already. My opinion is that they won't back off

[patience69]

I know that several people on this board have mentioned getting off this exchange. Does anyone know a specific reason that we would not qualify for the TSX? Is there something holding us up from moving to there?

[skys1]

patience, IMO, first, last, & always money. It costs much more to operated on a more senior exchange. Recently I heard a discussion by the CEO on this topic with another stock I have on the Venture

[patience69]

Thanks skys. So I guess it may be safe to assume that if money is coming from somewhere ie partner etc very soon that maybe an announcement of plans to move may be on the horizon. 

[Oilminerdeluxe]

Something will come next week, good or bad. This is the way.